Načítá se...

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

Epigallocatechin-3-gallate (EGCG) is a candidate for treatment of Alzheimer's disease (AD) but its inherent instability limits bioavailability and effectiveness. We found that EGCG displayed increased stability when formulated as dual-drug loaded PEGylated PLGA nanoparticles (EGCG/AA NPs). Oral...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Control Release
Hlavní autoři: Cano, Amanda, Ettcheto, Miren, Chang, Jui-Hsien, Barroso, Emma, Espina, Marta, Kühne, Britta A., Barenys, Marta, Auladell, Carmen, Folch, Jaume, Souto, Eliana B., Camins, Antoni, Turowski, Patric, García, Maria Luisa
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier Science Publishers 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6510952/
https://ncbi.nlm.nih.gov/pubmed/30876953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.03.010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!